Does RUXOLITINIB Cause Haemolysis? 50 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 50 reports of Haemolysis have been filed in association with RUXOLITINIB (OPZELURA). This represents 0.1% of all adverse event reports for RUXOLITINIB.
50
Reports of Haemolysis with RUXOLITINIB
0.1%
of all RUXOLITINIB reports
17
Deaths
22
Hospitalizations
How Dangerous Is Haemolysis From RUXOLITINIB?
Of the 50 reports, 17 (34.0%) resulted in death, 22 (44.0%) required hospitalization, and 12 (24.0%) were considered life-threatening.
Is Haemolysis Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for RUXOLITINIB. However, 50 reports have been filed with the FAERS database.
What Other Side Effects Does RUXOLITINIB Cause?
Off label use (12,492)
Death (6,561)
Fatigue (5,663)
Anaemia (3,593)
Haemoglobin decreased (3,297)
Platelet count decreased (3,028)
Diarrhoea (2,531)
Asthenia (2,529)
Dizziness (2,398)
Pneumonia (2,343)
What Other Drugs Cause Haemolysis?
ECULIZUMAB (1,476)
HUMAN IMMUNOGLOBULIN G (357)
RITUXIMAB (261)
RAVULIZUMAB-CWVZ (242)
PREDNISONE (192)
CYCLOSPORINE (173)
DEXAMETHASONE (167)
ACETAMINOPHEN (134)
VINCRISTINE (132)
TACROLIMUS (116)
Which RUXOLITINIB Alternatives Have Lower Haemolysis Risk?
RUXOLITINIB vs SABRIL
RUXOLITINIB vs SACCHAROMYCES CEREVISIAE
RUXOLITINIB vs SACITUZUMAB GOVITECAN
RUXOLITINIB vs SACITUZUMAB GOVITECAN-HZIY
RUXOLITINIB vs SACROSIDASE